An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)

Pulmonary sarcomatoid carcinoma (PSC) is an uncommon subtype of lung cancer, and immune checkpoint blockade promises in clinical benefit. However, virtually nothing is known about the expression of common immune checkpoints in PSC. Here, we performed immunohistochemistry (IHC) to detect nine immune-...

Descripció completa

Dades bibliogràfiques

Autors principals:	Haoyue Guo, Binglei Li, Li Diao, Hao Wang, Peixin Chen, Minlin Jiang, Lishu Zhao, Yayi He, Caicun Zhou
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2021-01-01
Col·lecció:	OncoImmunology
Matèries:	pulmonary sarcomatoid carcinoma immune checkpoint prognosis immunohistochemistry machine learning
Accés en línia:	http://dx.doi.org/10.1080/2162402X.2021.1947665
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!